Literature DB >> 19057143

Effects of beta-blocker on left ventricular remodeling in rats with volume overload cardiac failure.

Masayuki Kobayashi1, Noboru Machida, Ryou Tanaka, Yoshihisa Yamane.   

Abstract

The beneficial effects of beta-blockers on left ventricular (LV) remodeling have been reported in association with several conditions that cause heart failure, but their effects on the volume overloaded heart failure have not been well defined. Fifty Wistar rats that survived aortocaval (AC) shunt creation were randomly allotted into the following two groups: untreated animals (ACS; n=26) and animals treated with 100 mg/kg/day metoprolol (MP; ACS+MP; n=24). The effects of MP were evaluated at 1, 4 and 12 weeks post-surgery through echocardiographic, hemodynamic and pathologic studies. At 12 weeks post-surgery, LV wall thinning associated with chamber dilatation was observed in ACS but not in ACS+MP. LV end-diastolic pressure and diastolic wall stress were lower in ACS+MP than in ACS. The increase in LV weight was similar in both ACS and ACS+MP at 1 and 4 weeks post-surgery, but at 12 weeks post-surgery, it was significantly greater in ACS+MP than in ACS. At the cellular level, although the cardiac myocyte length progressively increased to a similar extent in both groups, the mean cross-sectional diameter of these cells in ACS+MP was greater than in ACS. In conclusion, MP did not prevent early eccentric hypertrophy in response to volume overload. However, in the late phase of volume overload-induced heart failure, MP appears to allow for myocyte cross-sectional growth and thus prevents LV wall thinning, resulting in a net increase in LV mass. In this manner, MP might contribute to reduction of diastolic wall stress and thereby delay progression of heart failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057143     DOI: 10.1292/jvms.70.1231

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

1.  Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure.

Authors:  Daniel Soetkamp; Romain Gallet; Sarah J Parker; Ronald Holewinski; Vidya Venkatraman; Kiel Peck; Joshua I Goldhaber; Eduardo Marbán; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2021-10-13       Impact factor: 17.367

2.  Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.

Authors:  Elia C El Hajj; Milad C El Hajj; Van K Ninh; Jason D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

Review 3.  Extracellular matrix remodeling during the progression of volume overload-induced heart failure.

Authors:  Kirk R Hutchinson; James A Stewart; Pamela A Lucchesi
Journal:  J Mol Cell Cardiol       Date:  2009-06-11       Impact factor: 5.000

4.  Regulation of the instantaneous inward rectifier and the delayed outward rectifier potassium channels by Captopril and Angiotensin II via the Phosphoinositide-3 kinase pathway in volume-overload-induced hypertrophied cardiac myocytes.

Authors:  Zikiar V Alvin; Graham G Laurence; Bernell R Coleman; Aiqiu Zhao; Majd Hajj-Moussa; Georges E Haddad
Journal:  Med Sci Monit       Date:  2011-07

5.  Genetic deletion of calcium/calmodulin-dependent protein kinase type II delta does not mitigate adverse myocardial remodeling in volume-overloaded hearts.

Authors:  Belal A Mohamed; Manar Elkenani; Joanna Jakubiczka-Smorag; Eric Buchholz; Sabrina Koszewa; Dawid Lbik; Moritz Schnelle; Gerd Hasenfuss; Karl Toischer
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

6.  Cardiac remodeling secondary to chronic volume overload is attenuated by a novel MMP9/2 blocking antibody.

Authors:  Lena Cohen; Irit Sagi; Einat Bigelman; Inna Solomonov; Anna Aloshin; Jeremy Ben-Shoshan; Zach Rozenbaum; Gad Keren; Michal Entin-Meer
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

7.  Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis.

Authors:  Dongsheng He; Jun Hu; Ying Li; Xiaofei Zeng
Journal:  Front Cardiovasc Med       Date:  2022-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.